| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8958046 | American Journal of Obstetrics and Gynecology | 2018 | 9 Pages |
Abstract
Intravenous immunoglobulin treatment in mothers pregnant with a fetus at risk for hemolytic disease seems to have a potential clinically relevant, beneficial effect on the course and severity of the disease. Confirmation in a multicenter randomized trial is needed.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Carolien MD, Johanna G. MD, PhD, Inge L. MD, PhD, Nan PhD, Enrico MD, PhD, John MD, PhD, Roland MD, PhD, Pauline E. BSc, Marie Anne MD, PhD, Eleonor MD, PhD, Kenneth J. MD, PhD, Karl-Philip MD, PhD, Mark D. MD, PhD, Timothy G. MD, Ditte S. MD,